Sponsor or institution
Clinical trials and research at Loxigen, INC.
As of November 12, 2026, Find a Trial lists 2 NIH-funded research projects at this institution, with $2.0 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2NIH research projects
NIH-funded research (2)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
LOX-blocking drugs for chemo-resistant triple-negative breast cancer
This work is creating new drugs that block a protein called LOX to help people whose triple-negative breast cancer has stopped responding to chemotherapy.
-
Creating new drugs to fight chemotherapy-resistant triple negative breast cancer
This study is working on new medications that can help make chemotherapy more effective for people with triple negative breast cancer by targeting a protein called lysyl oxidase, which can make tumors resistant to treatment.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.